| Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology GM Goodwin, PM Haddad, IN Ferrier, JK Aronson, TRH Barnes, ... Journal of Psychopharmacology 30 (6), 495-553, 2016 | 817 | 2016 |
| The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders I Pacchiarotti, DJ Bond, RJ Baldessarini, WA Nolen, H Grunze, RW Licht, ... American Journal of Psychiatry 170 (11), 1249-1262, 2013 | 761 | 2013 |
| NMDA-dependent modulation of CA1 local circuit inhibition HC Grunze, DG Rainnie, ME Hasselmo, E Barkai, EF Hearn, ... Journal of Neuroscience 16 (6), 2034-2043, 1996 | 556 | 1996 |
| The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders M Tohen, E Frank, CL Bowden, F Colom, SN Ghaemi, LN Yatham, ... Bipolar disorders 11 (5), 453-473, 2009 | 541 | 2009 |
| Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology GM Goodwin Journal of Psychopharmacology 17 (2), 149-173, 2003 | 533 | 2003 |
| A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder GM Goodwin, CL Bowden, JR Calabrese, H Grunze, S Kasper, R White, ... Journal of Clinical Psychiatry 65 (3), 432-441, 2004 | 511 | 2004 |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of … H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Moeller, ... The World Journal of Biological Psychiatry 14 (3), 154-219, 2013 | 496 | 2013 |
| Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as … GS Leverich, LL Altshuler, MA Frye, T Suppes, SL McElroy, PE Keck Jr, ... American Journal of Psychiatry 163 (2), 232-239, 2006 | 492 | 2006 |
| A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder CL Bowden, H Grunze, J Mullen, M Brecher, B Paulsson, M Jones, ... Journal of Clinical Psychiatry 66 (1), 111-121, 2005 | 492 | 2005 |
| Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial M Tohen, W Greil, JR Calabrese, GS Sachs, LN Yatham, ... American Journal of Psychiatry 162 (7), 1281-1290, 2005 | 475 | 2005 |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar … H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Möller, ... The World Journal of Biological Psychiatry 11 (2), 81-109, 2010 | 472 | 2010 |
| Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups M Schaefer, F Schmidt, C Folwaczny, R Lorenz, G Martin, N Schindlbeck, ... Hepatology 37 (2), 443-451, 2003 | 468 | 2003 |
| Factors associated with suicide attempts in 648 patients with bipolar disorder in the Stanley Foundation Bipolar Network GS Leverich, LL Altshuler, MA Frye, T Suppes, PE Keck Jr, SL McElroy, ... Journal of Clinical Psychiatry 64 (5), 506-515, 2003 | 466 | 2003 |
| Correlates of overweight and obesity in 644 patients with bipolar disorder SL McElroy, MA Frye, T Suppes, D Dhavale, PE Keck, GS Leverich, ... Journal of Clinical Psychiatry 63 (3), 207-213, 2002 | 450 | 2002 |
| The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania H Grunze, E Vieta, GM Goodwin, C Bowden, RW Licht, HJ Moeller, ... The World Journal of Biological Psychiatry 10 (2), 85-116, 2009 | 434 | 2009 |
| World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders, part I: treatment of bipolar depression H Grunze, S Kasper, G Goodwin, C Bowden, D Baldwin, R Licht, E Vieta, ... The World Journal of Biological Psychiatry 3 (3), 115-124, 2002 | 431 | 2002 |
| Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder1 RW Kupka, LL Altshuler, WA Nolen, T Suppes, DA Luckenbaugh, ... Bipolar disorders 9 (5), 531-535, 2007 | 427 | 2007 |
| Early-onset bipolar disorder and treatment delay are risk factors for poor outcome in adulthood RM Post, GS Leverich, RW Kupka, PE Keck Jr, SL McElroy, LL Altshuler, ... The Journal of clinical psychiatry 71 (7), 5308, 2010 | 424 | 2010 |
| Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline RM Post, LL Altshuler, GS Leverich, MA Frye, WA Nolen, RW Kupka, ... The British Journal of Psychiatry 189 (2), 124-131, 2006 | 420 | 2006 |
| Adenosine inhibition of mesopontine cholinergic neurons: implications for EEG arousal DG Rainnie, HCR Grunze, RW McCarley, RW Greene Science 263 (5147), 689-692, 1994 | 400 | 1994 |
